From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, Rockville, MD 20857.
D000284:Administration, Oral; D000741:Anemia, Aplastic / Q000139:chemically induced; D000927:Anticonvulsants / Q000009:adverse effects*; D004304:Dosage Forms; D004349:Drug Packaging; D004335:Drug and Narcotic Control; D004869:Equipment Safety; D000078328:Felbamate; D005511:Food Handling / Q000592:standards*; D005517:Foodborne Diseases / Q000517:prevention & control; D006801:Humans; D048448:Phenylcarbamates; D011409:Propylene Glycols / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000927:Anticonvulsants; D004304:Dosage Forms; D048448:Phenylcarbamates; D011409:Propylene Glycols; D000078328:Felbamate